If in fact future studies robustly establish a beneficial effect of the drug class in HF, it may allow for broader adoption of GLP-1 RAs in the prevalent CVD, ultimately contributing to addressing the unmet medical need that continues to persist in the prevention or management of, in particular, HFpEF
Mazdutide , cagrilintide , and orforglipron (an oral GLP-1 agonist) represent additional next-generation options that could offer different benefit-risk profiles for endometriosis patients
Turton, M
About 30 to 40 percent of commercial plans cover Wegovy or Zepbound for obesity, usually with prior authorization requirements (BMI thresholds, documented diet and exercise attempts, sometimes step therapy)
When comparing the two groups, researchers found that patients taking a GLP-1 medication had up to a 29% higher risk of developing a chronic cough within the first five years of treatment